Completed OBSERVATIONAL NCT00603551

Screening of Bone Mineral Density in Women Who Have Received Chemotherapy

Sponsor: Medical University of South Carolina

Updated 7 times since 2017 Last updated: Jun 18, 2018 Started: Nov 30, 2006 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00603551, this observational or N/A phase trial focuses on Bone Density and Cancer and remains completed. Sponsored by Medical University of South Carolina, it has been updated 7 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2018 — Jan 2021 [monthly]

Completed

Status: Unknown Status → Completed
Jun 2018 — Jul 2018 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina
National Center for Research Resources (NCRR)
Wyeth is now a wholly owned subsidiary of Pfizer

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States